中国生物工程杂志

［1］ Paradisi S, Sacchetti B, Balduzzi M, et al.Astrocyte modulation of in vitro betaamyloid neurotoxicity. Glia,2004，46(3): 252260. 
［2］ Kato H, Araki T, Imai Y, et al. Protection of dopaminergic neurons with a novel astrocyte modulating agent (R)()2propyloctanoic acid (ONO2506) in an MPTPmouse model of Parkinson’s disease. J Neurol Sci, 2003，208(12):915. 
［3］ Kasischke K A, Vishwasrao H D, Fisher P J, et al. Neural activity triggers neuronal oxidative metabolism followed by astrocytic glycolysis. Science, 2004 ，305(5680):99103. 
［4］ Hama H, Hara C, Yamaguchi K, et al. PKC signaling mediates global enhancement of excitatory synaptogenesis in neurons triggered by local contact with astrocytes. Neuron, 2004 ，41(3):405415. 
［5］ Brown D R. Neurons depend on astrocytes in a coculture system for protection from glutamate toxicity. Mol Cell Neurosci, 1999,13(5):379389. 
［6］ Amano S, Ohashi M, Ishiko T, et al. Humoral factors derived from glial cells protect cultured neuroblastoma cells against glutamate toxicity. Brain Res, 1994, 645(12):347350. 
［7］ Langeveld C H, Jongenelen C A, Schepens E, et al. Cultured rat striatal and cortical astrocytes protect mesencephalic dopaminergic neurons against hydrogen peroxide toxicity independent of their effect on neuronal development. Neurosci Lett, 1995,192(1): 1316. 
［8］ Bronstein D M, PerezOtano I, Sun V, et al. Gliadependent neurotoxicity and neuroprotection in mesencephalic cultures.Brain Res, 1995,704(1):112116. 
［9］ Saura J, Pares M, Bove J, et al. Intranigral infusion of interleukin1［beta］ activates astrocytes and protects from subsequent 6hydroxydopamine neurotoxicity. J Neurochem, 2003,85(3):651661. 
［10］ Giordano G, Kavanagh T J, Costa L G. Mouse cerebellar astrocytes protect cerebellar granule neurons against toxicity of the polybrominated diphenyl ether (PBDE) mixture DE71.Neurotoxicology, 2009 ,30(2):326329. 
［11］ Sandhu J K, Gardaneh M, Iwasiow R, et al. Astrocytesecreted GDNF and glutathione antioxidant system protect neurons against 6OHDA cytotoxicity.Neurobiol Dis, 2009, 33(3):405414. 
［12］ Anderl J L, Redpath S, Ball A J. A neuronal and astrocyte coculture assay for high content analysis of neurotoxicity. J Vis Exp, 2009,27:1173. 
［13］ Satoh T, Okamoto S I, Cui J, et al. Activation of the Keap1/Nrf2 pathway for neuroprotection by electrophillic phaseⅡ inducers. Proc Natl Acad Sci USA,2006, 103(3):768773. 
［14］ Kraft A D, Johnson D A, Johnson J A. Nuclear factor E2related factor 2dependent antioxidant reoponse element activation by tertButylhydroquinone and Sulforphane occurring preferentially in astrocytes conditions neurons against oxidative insult. J Neurosci, 2004,24(5):11011112. 
［15］ Kobayashi A, Ito E, Toki T, et al. Molecular cloning and functional characterization of a new Cap'n' collar family transcription factor Nrf3. J Biol Chem, 1999,274(10):64436452. 
［16］ Derjuga A, Gourley T S, Holm T M, et al. Complexity of CNC transcription factors as revealed by gene targeting of the Nrf3 locus. Mol Cell Biol, 2004,24(8):32863294. 
［17］ Sankaranarayanan K, Jaiswal A K. Nrf3 Negatively Regulates Antioxidantresponse Elementmediated Expression and Antioxidant Induction of NAD(P)H:Quinone Oxidoreductase1 Gene. J Biol Chem, 2004,279(9):5081050817. 
［18］ Long D J, Waikel R L, Wang X J, et al. NAD(P)H: quinone oxidoreductase 1 deficiency and increased susceptibility to 7,12dimethylbenz［a］anthraceneinduced carcinogenesis in mouse skin. J Nati Cancer Inst, 2001,93(5):11661170. 
［19］ Duffy S, So A, Murphy T H. Activation of endogenous antioxidant defenses in neuronal cells prevents free radicalmediated damage. J Neurochem, 1998,71(1):6977.